botensilimab,balstilimab
agenus
esmo world congress ready for presenting treatment progress in mss crc with fc-enhanced ctla-4 pd1 #wcgic2022 @ barcelona, spain 
President & Chief Executive Officer $INKT Accelerating treatments & access for life-threatening immune diseases. Tweets=my own #digitalhealth #Immunotherapy